Mark Stanley Berger, CMO at Actinium Pharmaceuticals, holds 23.06K shares in Genprex (Ticker: GNPX), holds 22.50K shares in Actinium Pharmaceuticals (Ticker: ATNM).
What is the percentage of profitable transactions made by Mark Stanley Berger?
The percentage of profitable transactions made by Mark Stanley Berger is 0%.
What is the average return per transaction made by Mark Stanley Berger?
The average return per transaction made by Mark Stanley Berger is -52.90%.
What stocks does Mark Stanley Berger hold?
Mark Stanley Berger holds: ATNM, GNPX stocks.
What was Mark Stanley Berger’s latest transaction?
Mark Stanley Berger latest transaction was an Uninformative Buy of ―.
What was Mark Stanley Berger's most profitable transaction?
Mark Stanley Berger’s most profitable transaction was an Informative Buy of ATNM stock on March 7, 2019. The return on the trade was -49.30%.
What is Mark Stanley Berger's role in Actinium Pharmaceuticals?
Mark Stanley Berger's role in Actinium Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.